GlaxoSmithKline will pay $3 billion to settle criminal charges

Share this article:

In what is the biggest healthcare fraud settlement in U.S. history, drug maker GlaxoSmithKline will pay $3 billion and plead guilty to illegally promoting prescription drugs. Among other criminal charges brought by the Department of Health and Human Services, GSK pleaded guilty for failing to include safety data about the diabetes drug Avandia in reports to the Food and Drug Administration. According to the Department of Justice, GSK did not disclose post-marketing studies related to Avandia's cardiovascular safety. Since 2007, Avandia has carried black box warnings about the potential increased risk of congestive heart failure, and myocardial infarction, according to court documents. It was pulled from retail pharmacy shelves last year.

Share this article:

More in Products

LeadingAge's CAST releases medication management tools

LeadingAge's Center for Aging Services Technologies release new tools last week to help long-term care providers identify the best medication management product.

Butler Mobility updates paint colors for platform lifts

Butler Mobility updates paint colors for platform lifts

Butler Mobility has widened the spectrum of paint color choices for its Incline Platform Lifts line.

NeuroMetrix releases pain management system

NeuroMetrix releases pain management system

NeuroMetrix Inc. has created the SENSUS™ Pain Management System, a wearable neurostimulation technology developed for chronic neuropathic pain, including painful diabetic neuropathy.